Log In
Print
BCIQ
Print
Print this Print this
 

UshStat

  Manage Alerts
Collapse Summary General Information
Company Oxford BioMedica plc
DescriptionLentiVector-based gene therapy expressing a gene encoding myosin VIIA (MYO7A; USH1B)
Molecular Target
Mechanism of ActionGene therapy
Latest Stage of DevelopmentPhase I/II
IndicationRetinitis
Partner

Sanofi
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today